Y-Biologics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	275.94	38,922	9,083	20,535	12,614	16,873
Short-Term Investments	38,189	3,031	3,000	362.11	368.9	74.96
Trading Asset Securities	2,704	2,316	120.49	-	-	-
Cash & Short-Term Investments	41,169	44,269	12,204	20,898	12,983	16,948
Cash Growth	296.46%	262.75%	-41.60%	60.97%	-23.40%	-49.24%
Accounts Receivable	48.75	25.96	63.87	573.37	689.88	825.19
Other Receivables	293.97	238.41	27.78	21.97	0.67	317.93
Receivables	342.72	264.37	91.64	595.34	690.55	1,143
Prepaid Expenses	144.05	50.44	42.91	89.29	20.2	91.4
Other Current Assets	822.94	231.05	132.56	180.33	845.17	1,663
Total Current Assets	42,479	44,815	12,471	21,763	14,538	19,845
Property, Plant & Equipment	7,319	6,899	7,407	8,009	10,801	16,824
Long-Term Investments	1,624	2,049	89.03	-	-	-
Other Intangible Assets	492.87	530.88	223.37	247.18	316.56	279.35
Other Long-Term Assets	1,996	1,504	1,538	275.5	3,667	1,296
Total Assets	53,910	55,798	21,727	30,294	29,323	38,245
Accounts Payable	33.25	0.27	3.23	1.21	-	-
Accrued Expenses	203.83	214.41	243.31	205.33	224.38	352.99
Short-Term Debt	40	65	-	2,000	-	-
Current Portion of Long-Term Debt	-	-	500	-	4,528	2,336
Current Portion of Leases	185.73	181	153.57	192.47	223.39	516.5
Other Current Liabilities	2,119	778.63	262	508.83	3,569	3,003
Total Current Liabilities	2,582	1,239	1,162	2,908	8,545	6,209
Long-Term Debt	15,212	14,366	-	500	-	2,528
Long-Term Leases	190.19	141.13	125.19	200.01	188.1	574.62
Other Long-Term Liabilities	13,509	13,454	802.45	677.72	645.96	491.76
Total Liabilities	31,493	29,200	2,090	4,286	9,379	9,803
Common Stock	7,589	7,589	7,391	7,381	6,145	6,141
Additional Paid-In Capital	176,041	176,041	124,295	122,727	93,385	93,287
Retained Earnings	-166,633	-162,315	-120,290	-113,849	-92,978	-74,173
Comprehensive Income & Other	5,420	5,283	6,960	7,149	5,741	3,186
Total Common Equity	22,417	26,597	18,356	23,408	12,293	28,441
Shareholders' Equity	22,417	26,597	19,637	26,008	19,943	28,441
Total Liabilities & Equity	53,910	55,798	21,727	30,294	29,323	38,245
Total Debt	15,628	14,753	778.76	2,892	4,940	5,955
Net Cash (Debt)	25,541	29,516	11,425	18,005	8,043	10,992
Net Cash Growth	164.82%	158.35%	-36.55%	123.86%	-26.83%	-60.80%
Net Cash Per Share	1703.90	1981.91	773.28	1438.09	654.40	903.42
Filing Date Shares Outstanding	15.2	15.18	14.78	14.76	12.29	12.17
Total Common Shares Outstanding	15.2	15.18	14.78	14.76	12.29	12.17
Working Capital	39,897	43,575	11,309	18,855	5,993	13,636
Book Value Per Share	1474.60	1752.35	1241.72	1585.65	1000.22	2337.50
Tangible Book Value	21,924	26,066	18,132	23,161	11,977	28,162
Tangible Book Value Per Share	1442.18	1717.38	1226.61	1568.90	974.46	2314.54
Land	749.16	749.16	749.16	594.79	594.79	594.79
Buildings	4,326	4,326	4,326	3,370	3,370	3,370
Machinery	11,514	10,781	10,580	10,479	12,144	11,635
Construction In Progress	359.39	340.51	317.23	377.82	301.48	3,703